IGF1 and breast cancer: CTP class B patients who were reclassified as IGF-CTP class C (BC group) also had a worse prognosis than patients classified as class B by both the CTP and the IGF-CTP classification systems (BB group) (HR = 4.70, 95% CI = 1.10–20.16, P = .04).